MedPath

PREVNAR 20

PREVNAR 20

Approved
DIN Number

02527049

Drug Class

Human

Market Date

Jul 8, 2022

Company
HC

Pfizer Canada Ulc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02527049
AIG Number2163621001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07AL02 PNEUMOCOCCUS, PURIFIED POLYSACC.ANTIGEN CONJUGATED
Product Specifications
Dosage FormSuspension
Route of AdministrationIntramuscular
AHFS Classification80:12.00
Health Canada Classification

ACTIVE INGREDIENTS (21)

CORYNEBACTERIUM DIPHTHERIAE CRM-197 PROTEINActive
Strength: 51 MCG / 0.5 ML
Monograph: CORYNEBACTERIUM DIPHTHERIAE CRM-197 PROTEIN
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1Active
Strength: 2.2 MCG / 0.5 ML
Monograph: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10AActive
Strength: 2.2 MCG / 0.5 ML
Monograph: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11AActive
Strength: 2.2 MCG / 0.5 ML
Monograph: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12FActive
Strength: 2.2 MCG / 0.5 ML
Monograph: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14Active
Strength: 2.2 MCG / 0.5 ML
Monograph: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15BActive
Strength: 2.2 MCG / 0.5 ML
Monograph: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CActive
Strength: 2.2 MCG / 0.5 ML
Monograph: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19AActive
Strength: 2.2 MCG / 0.5 ML
Monograph: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19FActive
Strength: 2.2 MCG / 0.5 ML
Monograph: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22FActive
Strength: 2.2 MCG / 0.5 ML
Monograph: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23FActive
Strength: 2.2 MCG / 0.5 ML
Monograph: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3Active
Strength: 2.2 MCG / 0.5 ML
Monograph: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33FActive
Strength: 2.2 MCG / 0.5 ML
Monograph: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4Active
Strength: 2.2 MCG / 0.5 ML
Monograph: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5Active
Strength: 2.2 MCG / 0.5 ML
Monograph: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6AActive
Strength: 2.2 MCG / 0.5 ML
Monograph: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6BActive
Strength: 4.4 MCG / 0.5 ML
Monograph: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7FActive
Strength: 2.2 MCG / 0.5 ML
Monograph: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8Active
Strength: 2.2 MCG / 0.5 ML
Monograph: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9VActive
Strength: 2.2 MCG / 0.5 ML
Monograph: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.